↓ Skip to main content

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
18 X users
patent
14 patents
guideline
1 clinical guideline source

Readers on

mendeley
134 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer
Published in
Journal of Clinical Oncology, December 2013
DOI 10.1200/jco.2012.48.5268
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
France 2 1%
China 1 <1%
Unknown 131 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 18 13%
Researcher 17 13%
Student > Ph. D. Student 15 11%
Other 12 9%
Student > Bachelor 12 9%
Other 36 27%
Unknown 24 18%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 53 40%
Biochemistry, Genetics and Molecular Biology 9 7%
Agricultural and Biological Sciences 9 7%
Nursing and Health Professions 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 17 13%
Unknown 33 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2026.
All research outputs
#1,594,326
of 34,208,280 outputs
Outputs from Journal of Clinical Oncology
#4,393
of 32,244 outputs
Outputs of similar age
#14,626
of 375,865 outputs
Outputs of similar age from Journal of Clinical Oncology
#41
of 239 outputs
Altmetric has tracked 34,208,280 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,244 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 375,865 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.